Mindfulness Programs for Breast Cancer Survivors

E-Mindfulness Approaches for Living After Breast Cancer

Recruiting Phase 3 Interventional Study
Breast Cancer Depression
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Pivotal Trial This treatment is in the last trial phase before FDA approval. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 50
Sex
Any
Trial phase
Phase 3
Study type
Interventional
Purpose
Prevention
Participants needed
402 (estimated)
Sponsor
NRG Oncology · Other
Who this trial is looking for

This trial is looking for younger women who have survived breast cancer and are experiencing depression. Participants will try two different mindfulness programs, one led by an instructor via Zoom and the other through a mobile app.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am between 18 and 50 years old.
  • I have been diagnosed with non-metastatic breast cancer.
  • I completed my main breast cancer treatments at least 6 months ago.
  • I score between 5 and 14 on the depression questionnaire.
  • I can understand and communicate in English or Spanish.
  • I am willing to take part in a 6-week mindfulness program.
  • I can use a smartphone or tablet.
  • I am female.

You may not be able to join if

  • I score less than 5 or more than 14 on the depression questionnaire.
  • I have had recurrent or metastatic breast cancer.
  • I have a history of another cancer, except for certain skin cancers.
  • I am currently pregnant or planning to get pregnant soon.
  • I am enrolled in other cancer-related trials that involve frequent assessments.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
NRG-CC015 is a prospective, randomized phase III clinical trial to evaluate the efficacy of two distinct digital approaches for delivering a mindfulness-based intervention: a live, instructor-led version delivered over Zoom (MAPs LO), and an app-based, self-paced version (MAPs App). Participants will include younger breast cancer survivors (BCS) who were diagnosed with breast cancer at or before a…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * The participant or a legally authorized representative must provide study-specific informed consent prior to pre-entry and, for participants treated in the U.S., authorization permitting release of personal health information. * The participant must have been greater than or e…
Contacts

Director Regulatory Affairs

412-339-5300

langerj@nrgoncology.org

CONTACT

Norman Wolmark, MD

CONTACT